HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marshall Horwitz Selected Research

Cyclic neutropenia

4/2004Hereditary neutropenia: dogs explain human neutrophil elastase mutations.
1/2004Paradoxical homozygous expression from heterozygotes and heterozygous expression from homozygotes as a consequence of transcriptional infidelity through a polyadenine tract in the AP3B1 gene responsible for canine cyclic neutropenia.
1/2004Congenital and acquired neutropenia.
9/2003Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase.
1/2003Role of neutrophil elastase in bone marrow failure syndromes: molecular genetic revival of the chalone hypothesis.
11/2002Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marshall Horwitz Research Topics

Disease

8Autosomal Recessive 3 Severe Congenital Neutropenia
04/2004 - 11/2002
6Cyclic neutropenia
04/2004 - 11/2002
6Neutropenia
04/2004 - 04/2003
5Leukemia
01/2006 - 02/2002
3Neoplasms (Cancer)
04/2005 - 01/2003
2Carcinoma (Carcinomatosis)
04/2005 - 01/2003
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2004 - 01/2004
1Carcinogenesis
12/2005
1Hematologic Neoplasms (Hematological Malignancy)
11/2004
1Genetic Translocation (Chromosomal Translocation)
11/2004
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2003
1Bone Marrow Failure Disorders
01/2003

Drug/Important Bio-Agent (IBA)

8Leukocyte Elastase (Neutrophil Elastase)IBA
04/2004 - 11/2002
3Proteins (Proteins, Gene)FDA Link
04/2004 - 02/2002
2dl1520 (ONYX-015)IBA
04/2005 - 01/2003
2Transcription Factors (Transcription Factor)IBA
11/2004 - 01/2004
2Adaptor Protein Complex 3IBA
04/2004 - 09/2003
2Peptide Hydrolases (Proteases)FDA Link
01/2004 - 09/2003
1EnzymesIBA
01/2006
1Oncogene Proteins (Oncogene Protein)IBA
12/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2005
1Oxidoreductases (Dehydrogenase)IBA
11/2004
1quinone (benzoquinone)IBA
11/2004
1NAD (NADH)IBA
11/2004
1Cadherins (E-Cadherin)IBA
11/2004
1Core Binding Factors (Core-Binding Factor)IBA
11/2004
1transcription factor NF-AT c3IBA
11/2004
1core binding factor alphaIBA
01/2004
1polyadenineIBA
01/2004
1Pharmaceutical PreparationsIBA
01/2004
1Notch ReceptorsIBA
01/2004
1Serine Proteases (Serine Protease)IBA
01/2004
1Insulin (Novolin)FDA Link
05/2003
1Pancreatic Elastase (Elastase)IBA
04/2003

Therapy/Procedure

1Intralesional Injections
01/2003
1Therapeutics
01/2003